Rani Jarkas: Cross-border Partnerships, M&A and VC Investment Thrive in China Life Science

China has declared it wants to be the world’s leader in drug innovation, and its life science sector made remarkable progress toward becoming a global leader in 2016. With China’s thirteenth Five-Year Plan reinforcing the country’s focus on “biological technology”, the cross-border partnerships, M&A and VC investment in China’s life science industry is set to boom.

Research also shows that most of the deal making activity was in support of drug development and commercialization. In 2015, striking deals for pharma assets has become a primary means of leveraging the burgeoning China market, which is now the number two pharmaceutical market in the world.

“In the world of China life science, VC investment, M&A transactions, partnering activity, especially cross-border deals – all of these metrics were up substantially last year,” said Greg B. Scott, CEO and Founder of ChinaBio? LLC, a consulting and advisory firm based in Shanghai.

One of the most remarkable things about this trend is that innovative SMEs are vital for the development of new products and services in the field of life sciences and medical technology.

Rani Jarkas, Chairman of Cedrus Investments, an investment pioneer with years of experience in biotech and life science sector, said, “Innovation is complex and not all the necessary expertise, facilities and funding are available in each company’s region. China’s pursuit of life science development will drive Chinese healthcare SMEs to seek cross-border collaboration in the global scope.”

Rani Jarkas, the Chairman of Cedrus Investments.

Rani Jarkas is a highly experienced financial services executive, with over 20 years of international banking experience. Currently, Mr. Jarkas is the Chairman of Cedrus Investments, a global boutique investment firm. Cedrus’ domain expertise is in life sciences, natural resources, energy, cleantech and nanotechnology. – Rani Jarkas

Advertisements

王雷(Rani Jarkas):生物医药跨境合作、并购和风险投资在中国蓬勃发展

中国已宣布了成为药物创新全球领军人物的目标,并且中国在2016年已取得了令人瞩目的进步。随着“十三五”计划的发布再次强调了国家重点发展“生物科技”的战略,中国生命科学产业的跨境合作、并购风险投资开始进入繁荣时代。

研究也表明大多数的交易活动都推动了药物发展和商业化。2015年,制药领域引人瞩目的交易都成为借助中国这一生机勃勃的全球第二大药品市场的主要方式。

总部在上海的咨询顾问公司ChinaBio?创始人兼执行总裁Greg B. Scott先生表示,“在中国生命科学领域,风险投资并购交易和合作活动,特别是跨境交易,都在去年取得了显著增加”。

值得注意的是,创新中小型企业生命科学医疗技术领域对新产品和服务的发展是至关重要的。

赛德思投资董事长王雷(Rani Jarkas)在生物科技领域有多年的投资经验。他表示:“创新本身是复杂的,在一国之内很难拥有所有必需的专业知识、设施和资金。中国对生命科学发展的追求将推动中国中小型医药企业在全球范围内寻求跨境合作。”

Rani Jarkas, the Chairman of Cedrus Investments.

Rani Jarkas is a highly experienced financial services executive, with over 20 years of international banking experience. Currently, Mr. Jarkas is the Chairman of Cedrus Investments, a global boutique investment firm. Cedrus’ domain expertise is in life sciences, natural resources, energy, cleantech and nanotechnology. – Rani Jarkas

Rani Jarkas: China pays great attention to youth football development

According to “The Mid- and Long-Term Development Plan for Chinese Soccer” issued in April by China’s National Development and Reform Commission, China aims to rank among the world top teams by 2050.

“By 2020, China will have 20,000 soccer academies. Chinese football teams, for both men and women, will present impressive results in World Cup, Asian Cup and Olympics,” the plan added.

Li Shuyi, Executive Deputy Director at the inter-ministerial joint conference office specializing in the country’s football development, believed a lot more needs to be done in order to make virtual progress in the sport. “We need to build a world-class backup system in Chinese national team operation”, said Li.

Most of all, China had embarked the youth football development program, aiming to dig deep on grassroots football. The development will be accelerated in schools. Schools with a specialty in football will expand from the current number of 5,000 to 20,000 by 2020 and further increase to 50,000 by 2025. There will be over 30 million primary and middle school students who often play soccer.

Rani Jarkas, Chairman of Cedrus Investments, who is also concerned about the development of China’s football, said, “Football academies are the motive force of the constant development of football. The future of China’s football will benefit greatly from its youth football development program.”

Rani Jarkas, the Chairman of Cedrus Investments.

Rani Jarkas is a highly experienced financial services executive, with over 20 years of international banking experience. Currently, Mr. Jarkas is the Chairman of Cedrus Investments, a global boutique investment firm. Cedrus’ domain expertise is in life sciences, natural resources, energy, cleantech and nanotechnology. – Rani Jarkas